OR WAIT 15 SECS
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
July 01, 2020
The COVID-19 pandemic has created a rise in demand for R&D and a shift in focus for some contract organizations.
June 30, 2020
The company now offers its CONFIDENCE virus clearance services to support validation of viral clearance processes.
July 01, 2018
This article highlights 15 years of changes in biopharmaceutical manufacturing.
May 15, 2017
Effective communication between contract manufacturing organizations and pharmaceutical company clients relies on well-defined master service and quality agreements.
FDA’s focus on the quality culture and its request for quality metrics may ensure a successful company-CMO relationship.
June 15, 2016
New drug approval policies promote industry growth and injectable contract manufacturing opportunities in China.
Biopharmaceutical manufacturers continue to put quality at the forefront of their relationships.
April 01, 2016
Careful planning, adequate staffing levels, and experienced project managers can help avoid pitfalls of transferring processes from one facility to another.
December 07, 2015
While stakeholders generally welcome improvements to quality initiatives, they are concerned with how the new requirements will be implemented for more complicated supply-chain models.
September 01, 2014
A well-constructed quality agreement can be an important tool to enable effective collaboration between owner and CMO.